These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25252918)

  • 1. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer.
    Santos M; Martínez-Fernández M; Dueñas M; García-Escudero R; Alfaya B; Villacampa F; Saiz-Ladera C; Costa C; Oteo M; Duarte J; Martínez V; Gómez-Rodriguez MJ; Martín ML; Fernández M; Viatour P; Morcillo MA; Sage J; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Paramio JM
    Cancer Res; 2014 Nov; 74(22):6565-6577. PubMed ID: 25252918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.
    Coe BP; Thu KL; Aviel-Ronen S; Vucic EA; Gazdar AF; Lam S; Tsao MS; Lam WL
    PLoS One; 2013; 8(8):e71670. PubMed ID: 23967231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
    Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
    Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.
    Liu T; Hou L; Huang Y
    Tumour Biol; 2014 Jul; 35(7):7239-47. PubMed ID: 24771265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.
    Ler LD; Ghosh S; Chai X; Thike AA; Heng HL; Siew EY; Dey S; Koh LK; Lim JQ; Lim WK; Myint SS; Loh JL; Ong P; Sam XX; Huang D; Lim T; Tan PH; Nagarajan S; Cheng CW; Ho H; Ng LG; Yuen J; Lin PH; Chuang CK; Chang YH; Weng WH; Rozen SG; Tan P; Creasy CL; Pang ST; McCabe MT; Poon SL; Teh BT
    Sci Transl Med; 2017 Feb; 9(378):. PubMed ID: 28228601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
    Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
    Bohrer LR; Chen S; Hallstrom TC; Huang H
    Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.
    Segovia C; Martínez-Fernández M; Dueñas M; Rubio C; López-Calderón FF; Costa C; Saiz-Ladera C; Fernández-Grajera M; Duarte J; Muñoz HG; de la Rosa F; Villacampa F; Castellano D; Paramio JM
    Oncotarget; 2017 Feb; 8(6):10531-10542. PubMed ID: 28060766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.
    Khan M; Walters LL; Li Q; Thomas DG; Miller JM; Zhang Q; Sciallis AP; Liu Y; Dlouhy BJ; Fort PE; Archer SM; Demirci H; Dou Y; Rao RC
    Lab Invest; 2015 Nov; 95(11):1278-90. PubMed ID: 26280220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.
    Hinz S; Kempkensteffen C; Christoph F; Hoffmann M; Krause H; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):331-6. PubMed ID: 17694325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rb-E2F transcriptional regulatory pathway in tumor angiogenesis and metastasis.
    Schaal C; Pillai S; Chellappan SP
    Adv Cancer Res; 2014; 121():147-182. PubMed ID: 24889531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas.
    Weikert S; Christoph F; Köllermann J; Müller M; Schrader M; Miller K; Krause H
    Int J Mol Med; 2005 Aug; 16(2):349-53. PubMed ID: 16012774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia.
    He Z; Zhang S; Ma D; Fang Q; Yang L; Shen S; Chen Y; Ren L; Wang J
    J Transl Med; 2019 Nov; 17(1):366. PubMed ID: 31711520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
    Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F
    Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation.
    Hubaux R; Thu KL; Coe BP; MacAulay C; Lam S; Lam WL
    J Thorac Oncol; 2013 Aug; 8(8):1102-6. PubMed ID: 23857401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
    Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
    Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 in Bladder Cancer, a Promising Therapeutic Target.
    Martínez-Fernández M; Rubio C; Segovia C; López-Calderón FF; Dueñas M; Paramio JM
    Int J Mol Sci; 2015 Nov; 16(11):27107-32. PubMed ID: 26580594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.